ArticleDermatology research and practice2012

RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and Therapy.

Ichiro Yajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.